Centricity Research LMC (Toronto)

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials
• Fatty liver disease (MASLD/MASH)1 trial
• Type 1 diabetes1 trial

Phase

• Phase 34 trials

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Novo Nordisk A/S4 trials

Running trials

• Active, not recruiting

  A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

  NCT07076199· Phase 3· Novo Nordisk A/S· Source

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Novo Nordisk A/S· Source

Closed trials

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· Phase 3· Novo Nordisk A/S· Source